Data as of May 20
| -0.09 / -1.62%|
The 6 analysts offering 12-month price forecasts for Threshold Pharmaceuticals Inc have a median target of 14.75, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +169.16% increase from the last price of 5.48.
The current consensus among 8 polled investment analysts is to Buy stock in Threshold Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.